Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Asieris, Astellas, Basilea, Beigene, Eusa, Shenzhen China Resources Gosun, Lianbio, Novavax, Senhwa, Sorrento.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Betterlife, Clinigen, Emmaus, Forma, Immune-Onc, Lilly, Oryzon, Praxis, Rafael, Supernus.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 180 Life Sciences, 3D, Abic, Agenus, Algae-C, Altimmune, Antibe, Applied Molecular, Aravive, Armis, Atyr, Axovant, Asymchem, Azurrx, Bach, Bone, Briacell, Brickbio, Caris, Cevec, Collplant, CSL Behring, Elevatebio, Guangzhou Baiyunshan, Helix, Hitgen, Insilico, Janssen, Kalos, Locus, Lonza, Mainpointe, Mallinckrodt, Merck, Mesentech, Point, Prelicel, Prestige, Qiagen, Recce, Renew, Roche, TCR2, Teva, Tscan, Valirx, Xphyto.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affibody, Agenus, American Gene Tech, Amgen, Arena, Astrazeneca, Corvus, Curevac, Denali, Eisai, Galapagos, Hepion, Immunitybio, Immunophotonics, Kiniksa, Merck, Mitsubishi, Nantkwest, Nicox, Onxeo, PDS, Quest, Rallybio, Revance, Sanifit, Verrica.

Biopharmas raising money in public or private financings, including: Adagio, Arch, Coimmune, Destiny, Edoc, Therapeuticsmd.

Quarterly snapshots from biopharma companies with marketed products, including: Catalyst, La Jolla, Neurocrine, Omeros, Zogenix.

New and updated preclinical and clinical data presented by biopharma firms at the Society for Immunotherapy of Cancer’s annual meeting Nov. 9-14, including: Adaptimmune, Alligator, Amphivena, Anaveon, Bolt, Checkmate, Cue, Dcprime, Elicio, Evelo, Exicure, F-star, Ikena, I-Mab, Immatics, Immutep, IMV, Infinity, Istari, Leap, Medigene, Nanobiotix, Neoleukin, Nkarta, Onconano, Phio, Repertoire, Sensei, Seven and Eight, Surface Oncology, Xencor.

New hires and promotions in the biopharma industry, including: Apnimed, Cerebral, Chinook, Genprex, IMV, Korro, Marinus, Nervgen, Novavax, Silverback.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Foundation Medicine, Nightware, Nuvasive.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Akida, Applied UV, Apyx Medical, Cleveland Clinic, Concept Medical, Epic, Orbusneich, P+F, Protec Scientific.